Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study29

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study11

Views

Views
July 20220
August 20222
September 20220
October 20222
November 20224
December 20221
January 20232
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Ireland2
 

Top cities views

Views
San Ramon7
Dublin2
Ashburn1
San Diego1